Epigenetics Drives Pharma Innovation

Epigenetics Drives Pharma Innovation

(2012) have summarized those compounds under scrutiny for use in the treatment of breast cancer (8). [...]recently, epigenetic changes had not been recognized as playing a significant role in the origin and progression of cancers. [...]the genesis and progression of tumors appears to be a complex pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Biopharm International 2013-01, Vol.26 (1), p.32
1. Verfasser: Morrow, K John
Format: Magazinearticle
Sprache:eng
Schlagworte:
Breast cancer
Cancer
Clinical trials
Disease
DNA methylation
Drugs
Epigenetics
Genomes
Medical research
Oncology
Pharmaceutical industry
Pharmaceuticals
R&D
Research & development
Tumors
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:(2012) have summarized those compounds under scrutiny for use in the treatment of breast cancer (8). [...]recently, epigenetic changes had not been recognized as playing a significant role in the origin and progression of cancers. [...]the genesis and progression of tumors appears to be a complex process in which DNA-based alterations can favor the development of epigenetic changes, which increase the malignant status of a particular cancer.
ISSN:1542-166X
1939-1862